Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease

被引:51
作者
Guan, ZZ
Nordberg, A
Mousavi, M
Rinne, JO
Hellström-Lindahl, E
机构
[1] Huddinge Univ Hosp, Karolinska Inst, NEUROTEC,Div Mol Neuropharmacol, Dept Clin Neurosci Occupat Therapy & Elderly Care, S-14186 Huddinge, Sweden
[2] Turku PET Ctr, FIN-20521 Turku, Finland
关键词
nicotinic acetylcholine receptor; Parkinson's disease; postmortem brain; receptor binding; RT-PCR; western blot;
D O I
10.1016/S0006-8993(02)03571-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Reductions in the number of neuronal nicotinic acetylcholine receptors (nAChRs) have been shown to occur in connection with Parkinson's disease (PD), but it is still unclear which subtype of this receptor is affected. In the present study we examined various nAChR subtypes employing ligand binding, as well as levels of subunit protein and mRNA in the brains of PD patients and age-matched controls. Binding of [3 H]epibatidine and levels of 0 mRNA in the caudate nucleus and temporal cortex, but not in the hippocampus were significantly decreased in the PD brain. The level of the alpha3 protein subunit was significantly reduced in all these brain regions but there was no change in the level of alpha4. The level of the beta2 protein subunit in the temporal cortex and hippocampus and the 2 mRNA inbeta the temporal cortex was lowered. Both the levels of the alpha7 subunit protein and [I-125]alpha-bungarotoxin binding were significantly increased in the temporal cortex of PD patients whereas the alpha mRNA level was unchanged. These findings reveal selective losses of the alpha3- and beta2-containing nAChRs and an increase in the alpha7 nAChRs that might be related to the pathogenesis of PD. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:358 / 366
页数:9
相关论文
共 57 条
  • [1] Schizophrenia, sensory gating, and nicotinic receptors
    Adler, LE
    Olincy, A
    Waldo, M
    Harris, JG
    Griffith, J
    Stevens, K
    Flach, K
    Nagamoto, H
    Bickford, P
    Leonard, S
    Freedman, R
    [J]. SCHIZOPHRENIA BULLETIN, 1998, 24 (02) : 189 - 202
  • [2] Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study
    Asahina, M
    Suhara, T
    Shinotoh, H
    Inoue, O
    Suzuki, K
    Hattori, T
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (02) : 155 - 163
  • [3] COMPARATIVE ALTERATIONS OF NICOTINIC AND MUSCARINIC BINDING-SITES IN ALZHEIMERS AND PARKINSONS DISEASES
    AUBERT, I
    ARAUJO, DM
    CECYRE, D
    ROBITAILLE, Y
    GAUTHIER, S
    QUIRION, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) : 529 - 541
  • [4] Cellular expression of α7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease -: A stereological approach
    Banerjee, C
    Nyengaard, JR
    Wevers, A
    de Vos, RAI
    Steur, ENHJ
    Lindstrom, J
    Pilz, K
    Nowacki, S
    Bloch, W
    Schröder, H
    [J]. NEUROBIOLOGY OF DISEASE, 2000, 7 (06) : 666 - 672
  • [5] Selective nicotinic receptor consequences in APPSWE transgenic mice
    Bednar, I
    Paterson, D
    Marutle, A
    Pham, TM
    Svedberg, M
    Hellström-Lindahl, E
    Mousavi, M
    Court, J
    Morris, C
    Perry, E
    Mohammed, A
    Zhang, X
    Nordberg, A
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2002, 20 (02) : 354 - 365
  • [6] Burghaus L, 2000, MOL BRAIN RES, V76, P385
  • [7] Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication
    Court, JA
    Piggott, MA
    Lloyd, S
    Cookson, N
    Ballard, CG
    McKeith, IG
    Perry, RH
    Perry, EK
    [J]. NEUROSCIENCE, 2000, 98 (01) : 79 - 87
  • [8] A NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT (ALPHA-7) IS DEVELOPMENTALLY REGULATED AND FORMS A HOMOOLIGOMERIC CHANNEL BLOCKED BY ALPHA-BTX
    COUTURIER, S
    BERTRAND, D
    MATTER, JM
    HERNANDEZ, MC
    BERTRAND, S
    MILLAR, N
    VALERA, S
    BARKAS, T
    BALLIVET, M
    [J]. NEURON, 1990, 5 (06) : 847 - 856
  • [9] β-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors:: In vitro and in vivo mechanisms related to Alzheimer's disease
    Dineley, KT
    Westerman, M
    Bui, D
    Bell, K
    Ashe, KH
    Sweatt, JD
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (12) : 4125 - 4133
  • [10] Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome
    Durany, N
    Zöchling, R
    Boissl, KW
    Paulus, W
    Ransmayr, G
    Tatschner, T
    Danielczyk, W
    Jellinger, K
    Deckert, J
    Riederer, P
    [J]. NEUROSCIENCE LETTERS, 2000, 287 (02) : 109 - 112